The relationship between Tcm-sestamibi uptake and ultrastructural cell types of thyroid tumours

Nuclear Medicine Communications

Volumn 22, Issue 1, 2001, Pages 39-44

  Sarikaya, A ^a   Huseyinova, G ^a   Irfanoglu M E ^a   Erkmen, N ^a   Cermik T F ^a   Berkarda, S ^a  

^a Departments of Nuclear Medicine   (Turkey)

Author keywords

Tcm MIBI; Thyroid tumour; Ultrastructural cell type

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADENOMA; ADULT; ARTICLE; BIOPSY; ELECTRON MICROSCOPY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR; ULTRASTRUCTURE; CELL SPECIFICITY; CELL TYPE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN CELL; HUMAN TISSUE; SURGICAL TECHNIQUE; TUMOR SCINTISCANNING;

ADENOMA; ADULT; BIOPSY; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS;

EID: 0034745778     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200101000-00006     Document Type: Article

References (44)

1. Baillet GY, Mena IG, Kuperus JH, Robertson JM, French WJ. Simultaneous technetium-99m-MIBI angiography and myocardial perfusion imaging. J Nucl Med 1989; 30: 38-44.
2. Hassan IM, Sahweil A, Constantinides C et al. Uptake and kinetics of Tc99m-hexakis-2-methoxyisobutylisonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989; 14: 333-340.
3. O'Tuama LA, Treves ST, Larar JN et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993; 34: 1045-1051.
4. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807.
5. Caner B, Kitapci M, Unlu M et al. Technetium-99m-MIBI uptake in benign and malignant lesions: a comparative study with technetium-99m-MDP. J Nucl Med 1992; 33: 319-324.
6. Földes I, Leveay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m-pertechnetate and technetium-99m-methoxyisobutylisonitrile. Eur J Nucl Med 1993; 20: 330-333.
7. Nakahara H, Noguchi S, Murakami N et al. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors. J Nucl Med 1996; 37: 901-904.
8. Kresnik E, Gallowitsch HJ, Mikosch P, Gomez I, Lind P. Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med 1997; 38: 62-65.
9. Wei JP, Burke GJ. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning. Ann Surg Oncol 1995; 2: 233-237.
10. Piwnica-Worms D, Kronauge J, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Circulation 1990; 82: 1826-1838.
11. Chiu ML, Kronauge JF, Worms DP. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblast. J Nucl Med 1990; 31: 1646-1653.
12. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556.
13. Carvalho PA, Chiu ML, Kronauge JF et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1521.
14. Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D, Vella A. Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi. J Nucl Med 1995; 36: 778-782.
15. Bénard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995; 36: 241-243.
16. Carpentier A, Jeannotte S, Verreault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: Relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998; 39: 1441-1444.
17. Thompson GB, Mullan BP, Grant CS et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery 1994; 116: 966-973.
18. Arbab AS, Koizumi K, Hemmi A et al. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med 1997; 1: 45-49.
19. Cutreno JA, Yospur LS, Klalkhalki I et al. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malign breast lesions. J Nucl Med 1998; 39: 449-453.
20. Staundenherz A, Abela C, Niederle B et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997; 24: 143-149.
21. Ishibashi M, Nishida H, Okuda S, Suekane S, Hayabuchi N. Localization of parathyroid glands in hemodialysis patients using Tc99m sestamibi imaging. Nephron 1998; 78: 48-53.
22. Staundenherz A, Leitha T. Is there a relationship between Tc99m sestamibi uptake and oxyphil cell content in hyperparathyroidism? (Letter) 1999; 40: 1402-1403.
23. Kao CH, Wang SJ, Liao SQ, Lin WY, Hsu CY. Quick diagnosis of hyperthyroidism with semiquantitative 30-min Tc99m-MIBI thyroid uptake. J Nucl Med 1993; 34: 71-74.
24. Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992; 33: 1396-1398.
25. Vattimo A, Bertelli P, Cintorino M et al. Hürthle cell tumor dwelling in hot thyroid nodules: Preoperative detection with technetium-99m-MIBI dual-phase scintigraphy. J Nucl Med 1998; 39: 822-825.
26. Learoyd DL, Roach PJ, Briggs GM, Delbridge LW, Wilmshurst EG, Robinson BG. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma. J Nucl Med 1997; 38: 227-230.
27. m-tetrofosmin. Nucl Med Commun 1999; 20: 353-359.
28. Miyamoto S, Kasagi K, Misaki T, Alam MS, Konishi J. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med 38: 352-356.
29. 99mTc-Q12 in vitro and in vivo. Nucl Med Biol 1998; 25: 233-240.
30. Delmon-Moingeon L, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davidson A, Jones AG. Uptake of the cation hexakis-(2-isobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.
31. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro technetium-99m-teberoxime in carcinoma cell lines and normal cells: Comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993; 34: 1949-1952.
32. Maublant J, Baggott J. Technetium-99m-sestamibi cellular uptake: passive or secondary active transport? J Nucl Med 1997; 38: 1170.
33. Bae KT, Piwnica-Worms D. Pharmacokinetic modeling of multidrug resistance P-glycoprotein transport of gamma-emitting substrates. Q J Nucl Med 1997; 41: 101-110.
34. Cordobes M, Starzec A, Delmon-Moingeon L et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cell: correlation with MDR gene expression. J Nucl Med 1996; 37: 286-289.
35. Raikhlin NT, David H, Lapish K. Ultrastructure of tumors in man. In: W. Raiklin, ed. Guidebook on diagnosis. Moscow: Moskva Medicina, 1981: 293-315.
36. Tarasov SS. The role of cytological research in the diagnosis of tumor-like diseases and tumors of the thyroid. Arkh Patol 1989; 51: 84-88.
37. Roediger WE. The oxyphil and C cells of the human thyroid gland. A cytochemical and histopathologic review. Cancer 1975; 36: 1758-1770.
38. Dickersin GR, Vickery Jr AL, Smith SB. Papillary carcinoma of the thyroid, oxyphil cell type, clear cell variant: a light- and electron-microscopic study. Am J Surg Pathol 1980; 4: 501-509.
39. Chan JK. Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 1990; 5: 241-257.
40. Tallini G, Carcangiu ML, Rosai J. Oncocytic neoplasms of the thyroid gland. Acta Pathol Jpn 1992; 42: 305-315.
41. Huseyinova G, Irfanoglu ME, Azizova GK. Ultrastructural anaplasia of mitochondria of oncocytes in malignant processes. (Abstract) Proceedings of European Congress on Electron Microscopy. Dublin: 1996; 3: 108-112.
42. Huseyinova G, Irfanoğlu ME, Kayapinar R, Mamedbeyova L, Azizova G, Isaev I. The ultrastructural anaplasia histogenesis and malignization onset of thyroid epithelial tumors (abstract). Proceedings of 13th National Electron Microscopy Congress with International Participation. Ankara: 1997; 141-144.
43. Mcbiles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid imaging. Semin Nucl Med 1995; 25: 221-234.
44. Pauwels EKJ, McCready VR, Stoot JHMB, Van Deurzen DFP. The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 1998; 25: 277-305.